Colvert, E. et al. Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry 72, 415–423 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Geschwind, D. H. & Flint, J. Genetics and genomics of psychiatric disease. Science 349, 1489–1494 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skuse, D. H., Mandy, W. P. L. & Scourfield, J. Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br. J. Psychiatry 187, 568–572 (2005).

Article  PubMed  Google Scholar 

Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285–299 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008–1021 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gilissen, C. et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344–347 (2014).

Article  CAS  PubMed  Google Scholar 

Guo, H. et al. Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes. Genet. Med. 21, 1611–1620 (2019).

Article  CAS  PubMed  Google Scholar 

Shim, J. S. et al. MEF2C-Related 5q14.3 microdeletion syndrome detected by array CGH: a case report. Ann. Rehabil. Med. 39, 482–487 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Wang, J. et al. Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype–phenotype correlation. BMC Med. Genet. 19, 191 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, W.-Z. et al. Targeted resequencing of 358 candidate genes for autism spectrum disorder in a Chinese cohort reveals diagnostic potential and genotype–phenotype correlations. Hum. Mutat. 40, 801–815 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Meur, N. et al. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J. Med. Genet. 47, 22–29 (2010).

Article  CAS  PubMed  Google Scholar 

Leifer, D. et al. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl Acad. Sci. USA 90, 1546–1550 (1993).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okamoto, S., Krainc, D., Sherman, K. & Lipton, S. A. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl Acad. Sci. USA 97, 7561–7566 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shalizi, A. et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311, 1012–1017 (2006).

Article  CAS  PubMed  Google Scholar 

Flavell, S. W. et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008–1012 (2006).

Article  CAS  PubMed  Google Scholar 

Harrington, A. J. et al. MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders. eLife 5, e20059 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Harrington, A. J. et al. MEF2C hypofunction in neuronal and neuroimmune populations produces MEF2C haploinsufficiency syndrome-like behaviors in mice. Biol. Psychiatry 88, 488–499 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbosa, A. C. et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc. Natl Acad. Sci. USA 105, 9391–9396 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).

Article  PubMed  Google Scholar 

Cai, Y. et al. In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway. Sci. Adv. 5, eaav3335 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770–788 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koblan, L. W. et al. In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice. Nature 589, 608–614 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newby, G. A. & Liu, D. R. In vivo somatic cell base editing and prime editing. Mol. Ther. 29, 3107–3124 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arbab, M. et al. Base editing rescue of spinal muscular atrophy in cells and in mice. Science 380, eadg6518 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng, T. L. et al. Expanding C-T base editing toolkit with diversified cytidine deaminases. Nat. Commun. 10, 3612 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Duan, Y. et al. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice. Nat. Biomed. Eng. 6, 168–180 (2022).

Article  CAS  PubMed  Google Scholar 

Zweier, M. et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum. Mutat. 31, 722–733 (2010).

Article  CAS  PubMed  Google Scholar 

Bienvenu, T., Diebold, B., Chelly, J. & Isidor, B. Refining the phenotype associated with MEF2C point mutations. Neurogenetics 14, 71–75 (2013).

Article  PubMed  Google Scholar 

Srivastava, S. et al. Clinical whole exome sequencing in child neurology practice. Ann. Neurol. 76, 473–483 (2014).

Article  PubMed  Google Scholar 

Vrečar, I. et al. Further clinical delineation of the MEF2C haploinsufficiency syndrome: report on new cases and literature review of severe neurodevelopmental disorders presenting with seizures, absent speech, and involuntary movements. J. Pediatr. Genet. 6, 129–141 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Feigin, V. L. et al. Burden of neurological disorders across the US from 1990–2017: a global burden of disease study. JAMA Neurol. 78, 165–176 (2021).

Article  PubMed  Google Scholar 

Tu, S. et al. NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nat. Commun. 8, 1488 (2017).

Article  PubMed  PubMed Central